AI Opportunities for Life Sciences R&D - with Andrew Bolt of Deloitte

AI Opportunities for Life Sciences R&D - with Andrew Bolt of Deloitte

0 Hinnangud
0
Osa
786 of 1070
Kestus
29 min
Keel
inglise
Vorming
Kategooria
Majandus ja ettevõtlus

Today's guest is Andrew Bolt, Partner at Deloitte. He joins Emerj CEO and Head of Research Daniel Faggella on today's podcast to talk about challenges in R&D for life sciences. While productivity has remained stagnant for the last 10-15 years, advances in AI-enhanced protein structure prediction are revolutionizing drug targeting and the very infrastructure of recruiting patients for clinical trials. Later, the two postulate on the ways AI can expedite regulatory compliance in pharmaceutical R&D in similar ways. Find out more about sponsored content and how to engage with the Emerj audience at emerj.com/ad1.


Loe ja kuula

Astu lugude lõputusse maailma

  • Suurim valik eestikeelseid audio- ja e-raamatuid
  • Proovi tasuta
  • Loe ja kuula nii palju, kui soovid
  • Lihtne igal ajal tühistada
Proovi tasuta
Device Banner Block-copy 894x1036
Cover for AI Opportunities for Life Sciences R&D - with Andrew Bolt of Deloitte

Muud podcastid, mis võivad sulle meeldida ...